Climb Bio Inc’s filing revealed that its CHIEF ACCOUNTING OFFICER Pimblett Emily unloaded Company’s shares for reported $2495.0 on Dec 19 ’24. In the deal valued at $2.02 per share,1,235 shares were sold. As a result of this transaction, Pimblett Emily now holds 11,329 shares worth roughly $22091.55.
Then, Pimblett Emily sold 1,191 shares, generating $9,741 in total proceeds. Upon selling the shares at $8.18, the CHIEF ACCOUNTING OFFICER now owns 7,564 shares.
Before that, Morisset Valerie sold 69,005 shares. Climb Bio Inc shares valued at $554,170 were divested by the EVP, R&D AND CSO at a price of $8.03 per share. As a result of the transaction, Morisset Valerie now holds 31,317 shares, worth roughly $61068.15.
Leerink Partners initiated its Climb Bio Inc [CLYM] rating to an Outperform in a research note published on December 02, 2024; the price target was $10.
Price Performance Review of CLYM
On Friday, Climb Bio Inc [NASDAQ:CLYM] saw its stock fall -2.99% to $1.95. Over the last five days, the stock has lost -2.50%. Climb Bio Inc shares have risen nearly 8.33% since the year began. Nevertheless, the stocks have fallen -28.31% over the past one year. While a 52-week high of $11.55 was reached on 01/07/25, a 52-week low of $1.73 was recorded on 01/14/25. SMA at 50 days reached $2.7066, while 200 days put it at $5.6017.
Levels Of Support And Resistance For CLYM Stock
The 24-hour chart illustrates a support level at 1.8900, which if violated will result in even more drops to 1.8300. On the upside, there is a resistance level at 2.0300. A further resistance level may holdings at 2.1100. The Relative Strength Index (RSI) on the 14-day chart is 40.03, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0190, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.08%. Stochastics %K at 40.74% indicates the stock is a holding.
How much short interest is there in Climb Bio Inc?
A steep rise in short interest was recorded in Climb Bio Inc stocks on 2024-12-31, dropping by 79459.0 shares to a total of 4.82 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 4.9 million shares. There was a decline of -1.65%, which implies that there is a negative sentiment for the stock.
